Introduction
============

At least 20 million people worldwide are infected with human T-cell leukemia virus type 1 (HTLV-1) ([@B23]; [@B5]; [@B65]). This retrovirus is prevalent in southwestern Japan, sub-Saharan Africa, the Caribbean islands, South America, the Middle East and Austro-Melanesia. Transmission occurs principally from mother to child via milk or between sexual partners through contaminated blood. Infected individuals are at risk of developing a rapidly progressive malignancy, adult T-cell leukemia/lymphoma (ATLL), and a debilitating neurologic condition, HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) ([@B66]).

Although frequently neglected in the field, bovine leukemia virus (BLV) is a useful model to address specific questions that cannot be answered in the HTLV-1 system ([@B49]; [@B46]). Both viruses are indeed closely related δ-retroviruses that induce hematological diseases. In the bovine species, the most prevalent clinical manifestation in about one-third of infected animals is persistent lymphocytosis, a benign accumulation of infected B-lymphocytes ([@B27]). In a minority of cases (about 5--10%), BLV infection can progress to fatal leukemia/lymphoma whose most dramatic consequence is spleen hypertrophy and disruption consecutive to tumor formation. BLV typically persists in less than 1% of peripheral blood cells, leading to an asymptomatic infection in the majority of infected animals. BLV is transmitted horizontally by direct contact, iatrogenic procedures or insect bites upon transfer of infected cells from milk, blood, and body fluids from heavily infected dams ([@B8]).

The Paradox: Htlv-1 Replication is Driven by Oncogenic Proteins that Expose the Infected Cell to the Host Immune Response
=========================================================================================================================

According to currently most accepted model, two viral proteins (Tax and HBZ, HTLV-1 bZIP) are hypothesized to have the highest impact on viral replication and cell transformation ([@B42]; [@B12]). The modes of action of Tax and HBZ are remarkably pleiotropic and involve a variety of cell signaling pathways (CREB, NF-κB, AKT, and TNF) ([@B62]; [@B10]). Tax inhibits tumor suppressors (p53, Bcl11B, and TP53INP1) and activates cyclin-dependent kinases (CDKs), both of these mechanisms leading to accelerated cell proliferation. Experimental evidence further shows that Tax drives tumor formation in transgenic mouse models, supporting its oncogenic potential. Through an interaction with the helicase complex (mcm2-7), Tax accelerates S phase progression by initiating additional replication origins. By promoting unscheduled cell growth, Tax also induces genomic instability and generates somatic alterations. Another viral protein, HBZ also favors cell proliferation by inhibiting apoptosis/senescence and modulating the cell cycle ([@B39]). In fact, the HBZ protein counteracts a series of Tax-activated viral and cellular pathways (such as NF-κB, Akt, and CREB). Transgenic expression of HBZ in CD4 + T cells induced T-cell lymphomas and systemic inflammation in mice, resembling diseases observed in HTLV-1 infected individuals ([@B55]).

A major issue of expression of viral proteins is initiation of the host immune response. Indeed, Tax induces a strong immune response that would be harmful to infected cells ([@B44]; [@B31]; [@B52]). In comparison, HBZ triggers a less efficient immunity that is consistent with low expression low expression throughout HTLV-1 infection ([@B40]). How does HTLV-1 persist despite a strong immune response against viral oncogenes that promote infected cell replication? The next paragraph lists the experimental evidence pertaining to this paradox.

Experimental Evidence and Interpretations
=========================================

Evidence 1: Infected Cells Proliferate Faster to Undergo Clonal Expansion
-------------------------------------------------------------------------

The BLV model has been instrumental to quantify the dynamics of cell turnover *in vivo* ([@B19]). Experiments based on intravenous injection of bromodeoxyuridine (BrdU) and carboxyfluorescein diacetate succinimidyl ester (CFSE) demonstrate that B-lymphocytes are proliferating significantly faster in BLV-infected sheep than in healthy controls ([@B13], [@B14]). Excess of proliferation is compensated by an increase in cell death, thereby maintaining homeostasis. Increased cell proliferation is also reported in HTLV-induced HAM/TSP using a similar strategy based on incorporation of deuterated glucose ([@B3]). *In vivo*, BLV and HTLV infection is thus characterized by an increased cell turnover, likely driven by viral oncogenes such as Tax and HBZ.

Evidence 2: 5′ LTR Directed Transcription Is Extremely Low *in Situ*
--------------------------------------------------------------------

The amount of viral RNA transcribed from the 5′ LTR promoter is extremely low *in vivo*. In primary tumor cells, only very sensitive techniques such as RT-PCR can identify viral RNA transcribed from the 5′ LTR promoter ([@B36]; [@B51]; [@B56]; [@B15]). It was initially concluded that the provirus is silent. However, *in situ* experiments showed that rare cells expressed large amounts of viral transcripts ([@B36]).

Evidence 3: Sense Transcription Can Be Activated by Various Stimuli
-------------------------------------------------------------------

The main regulatory element of the 5′ LTR promoter that is activated by Tax is a 21 bp enhancer that interacts with CREB/ATF transcription factors ([@B59]; [@B2]). This complex activates sense transcription when cells are isolated *ex vivo* from HTLV-1 carriers or BLV-infected sheep. This reactivation can further be increased by various stimuli such as polyclonal activators, HDAC inhibitors or oxygen deprivation ([@B33]; [@B1]; [@B60]; [@B37]; [@B45]; [@B35]).

Evidence 4: Immunity against Most Viral Antigens Is Extremely Efficient While HBZ Is Poorly Immunogenic
-------------------------------------------------------------------------------------------------------

Persistent infection by BLV and HTLV-1 is characterized by a permanent and vigorous immunity against viral antigens ([@B31]; [@B11]; [@B6]; [@B32]). This immune response efficiently controls viral replication *in vivo* as demonstrated in the BLV model ([@B20], [@B21], [@B18]; [@B24]). Among viral proteins, Tax is the immunodominant HTLV-1 antigen in the T-cell response ([@B30]; [@B26]). In contrast, the HBZ protein is very poorly immunogenic and expressed at very low levels in infected cells ([@B58]; [@B17]; [@B52]; [@B47]; [@B7]). Humoral immunity against HBZ protein is indeed particularly weak ([@B47]; [@B57]). However, cytotoxic T cells specific to HBZ but not to the immunodominant Tax are the most effective in the control of HTLV-1 ([@B40]). These results thus focus attention on the extremely low expression and low immunogenicity of HBZ.

Evidence 5: Antisense Transcripts and microRNAs Are Abundantly and Permanently Expressed in Tumors
--------------------------------------------------------------------------------------------------

In contrast to 5′ LTR directed transcription, antisense RNA synthesis initiating at the 3′ LTR is consistently identified in primary ATL cells and BLV tumors ([@B63]; [@B53]; [@B16]). In contrast to HTLV-1, BLV also abundantly transcribes a cluster of microRNAs from internal pol III promoters ([@B34]; [@B50]; [@B64]). These microRNAs are required for efficient viral replication and induction of pathogenesis ([@B25]).

Evidence 6: HBZ and AS RNAs are Mainly Localized in the Nucleus Suggesting a Role in Epigenetics
------------------------------------------------------------------------------------------------

The HBZ RNA is mainly localized in the nucleus, consistent with a low rate of translation ([@B28]; [@B48]; [@B56]; [@B38]; [@B47]). Although the function of the HBZ protein has been clearly evidenced, the dominant nuclear localization of the HBZ RNA thus suggests other regulatory roles such as for example epigenetic modulation of gene expression. In BLV, the antisense transcripts are not predicted to be translated but are rather primarily retained in the nucleus, hinting at a lncRNA-like role ([@B16]).

Evidence 7: Untranslated HBZ RNA Has a Function
-----------------------------------------------

The oncogenic role of the HBZ RNA was revealed by an untranslatable HBZ RNA (i.e., devoid of initiation codon) able to induce the proliferation of a human IL-2-dependent T-cell line (Kit225) ([@B54]). Microarray expression analysis reveals that HBZ RNA and protein differentially modulate the transcription of host genes. HBZ RNA activates the transcription of survivin and cell-cycle related genes ([@B43]). Thus, the HBZ gene has bimodal functions in two different molecular forms as a polypeptide and a ribonucleic acid. Notwithstanding important activities as protein, the scarcity of the HBZ polypeptide in tumor cells contrasts with the expression of the HBZ RNA. Therefore, main functions of HBZ are exerted by its RNA form. Although the level of expression of HBZ protein is unquestionably very low, the protein must nevertheless play an essential role in the life-cycle of the virus because the coding sequence has been conserved during evolution in presence of a protective host immune response.

Evidence 8: Alternate Transcription of Sense and Antisense Transcription
------------------------------------------------------------------------

Single cell analysis shows that the Tax RNA is expressed in bursts and is exported from the nucleus, whereas the majority of hbz RNA is retained ([@B9]). Time-lapse imaging of destabilized enhanced green fluorescent protein indicates that Tax expression is transient, fluctuates between on/off states and is detected only in HBZ-negative cells ([@B29]; [@B41]). Viral persistence is thus characterized by successive cycles of sense/antisense transcription. Evidence from single-molecular RNA-FISH nevertheless indicates a more complex relationship between expression of the two strands that are not transcribed in strict alternation ([@B9]).

A Model for Viral Persistence Under Immune Control
==================================================

These experimental evidences are consistent with the model presented in **Figure [1](#F1){ref-type="fig"}** and support Yoshida's paradigm.

![Hypothetical model combining temporal regulation of viral expression allowing escape from host immunity. Sense transcription (red arrow) directed by the 5′ LTR promoter allows translation of the TAX protein (red ellipse) and synthesis of the viral particle (red hexagon). The antisense strand is transcribed in a HBZ (HTLV-1) and (AS) BLV RNA (green arrow) and protein (ellipse hatched in red). BLV, but not HTLV, also encodes RNA polymerase III driven microRNAs (hatched green arrow). Burst of sense transcription (red line on the time graph at the left) transiently exposes infected cells to the immune response: cytotoxic T cells (CTL), antibodies from B-lymphocytes (B) and macrophages (mϕ). Silencing of sense transcription, for example by initiating antisense RNA synthesis (graph on the right) allows further cell proliferation.](fmicb-08-02684-g001){#F1}

BLV/HTLV proviruses are transcribed in both orientations. Sense transcription from the 5′ LTR (red arrow) generates genomic and spliced subgenomic RNAs (e.g., Tax). Translation of these RNAs into oncogenic proteins (Tax) triggers cell proliferation, mitosis, and clonal expansion of the infected cell. Synthesis of structural (gag, env) and enzymatic (protease, reverse transcriptase, and integrase) proteins are required for assembly of the viral particle (red hexagon) that will further colonize new target cells. The provirus is also transcribed in the antisense orientation from the 3′ LTR (green arrow) yielding HBZ and AS RNAs for HTLV and BLV, respectively. HBZ is very poorly translated while the coding potential of AS is ambiguous (hatched in red). Furthermore, the immunogenicity of HBZ is weak compared to all other viral antigens. BLV, but not HTLV, also encodes RNA polymerase III driven microRNAs (hatched green arrow). RNA synthesis from the 5′ LTR is mostly silent but burst of sense transcription (red line on the time graph) transiently exposes infected cells to the immune response (e.g., cytotoxic, humoral, and innate). The only option that allows survival is to silence sense transcription, for example by initiating antisense RNA synthesis (graph on the right). This simplified model is nevertheless incomplete because the infected cell is also exposed to the CTL response to HBZ providing that the protein is expressed. Experimental evidence indicates that the HBZ RNA is mostly nuclear and is therefore not translated. Single cell kinetics of RNA and protein expression would answer to this still unsolved question. Another issue is the role of the intrinsic immunity operating within virus-infected cells, i.e., restriction factors (RFs) inhibiting Tax function or reverse transcription of viral genome ([@B61]; [@B4]; [@B22]).

Conclusion
==========

Yoshida predicted that the Tax oncogene should be expressed in cycles to allow cell survival. Recent reports describing bursts between sense and antisense transcriptions are consistent with this hypothesis. Regular switches between 5′ and 3′ transcription indeed allows transient Tax expression and fast silencing of viral expression. This mechanism would allow Tax-driven cell proliferation and synthesis of viral particles in presence of the host immunity. This model thus illustrates the dynamic equilibrium between a virus attempting to proliferate under a tight control exerted by the immune response.
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